1250 related articles for article (PubMed ID: 11025665)
1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
Bergers G; Brekken R; McMahon G; Vu TH; Itoh T; Tamaki K; Tanzawa K; Thorpe P; Itohara S; Werb Z; Hanahan D
Nat Cell Biol; 2000 Oct; 2(10):737-44. PubMed ID: 11025665
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.
Nozawa H; Chiu C; Hanahan D
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12493-8. PubMed ID: 16891410
[TBL] [Abstract][Full Text] [Related]
3. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
Inoue M; Hager JH; Ferrara N; Gerber HP; Hanahan D
Cancer Cell; 2002 Mar; 1(2):193-202. PubMed ID: 12086877
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen generated by Nox1 triggers the angiogenic switch.
Arbiser JL; Petros J; Klafter R; Govindajaran B; McLaughlin ER; Brown LF; Cohen C; Moses M; Kilroy S; Arnold RS; Lambeth JD
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):715-20. PubMed ID: 11805326
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
Hashimoto G; Inoki I; Fujii Y; Aoki T; Ikeda E; Okada Y
J Biol Chem; 2002 Sep; 277(39):36288-95. PubMed ID: 12114504
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis.
Christofori G; Naik P; Hanahan D
Mol Endocrinol; 1995 Dec; 9(12):1760-70. PubMed ID: 8614412
[TBL] [Abstract][Full Text] [Related]
9. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
EXS; 1997; 79():233-69. PubMed ID: 9002222
[TBL] [Abstract][Full Text] [Related]
10. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro.
Park HY; Kwon HM; Lim HJ; Hong BK; Lee JY; Park BE; Jang Y; Cho SY; Kim HS
Exp Mol Med; 2001 Jun; 33(2):95-102. PubMed ID: 11460888
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Bausch D; Pausch T; Krauss T; Hopt UT; Fernandez-del-Castillo C; Warshaw AL; Thayer SP; Keck T
Angiogenesis; 2011 Sep; 14(3):235-43. PubMed ID: 21442180
[TBL] [Abstract][Full Text] [Related]
12. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
17. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
18. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL
Oncogene; 1998 Jul; 17(3):303-11. PubMed ID: 9690512
[TBL] [Abstract][Full Text] [Related]
19. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
